Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1992British Journal of Clinical PharmacologyOpen Access

Introducing NMDA antagonists into clinical practice: why head injury trials?

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRoss BullockJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ross Bullock (1992) studied this question.

synapsesocial.com/papers/6a01a428bd6301933f5caa72https://doi.org/10.1111/j.1365-2125.1992.tb05648.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Administration of Excitatory Amino Acid Antagonists via Microdialysis Attenuates the Increase in Glucose Utilization Seen following Concussive Brain Injury1992 · 247 citations
  2. 2Ischaemic brain damage is still common in fatal non-missile head injury.1989 · 506 citations
  3. 3Neurotransmitter-Mediated Mechanisms of Traumatic Brain Injury: Acetylcholine and Excitatory Amino Acids1992 · 215 citations
  4. 4Ischemic neuronal damage after acute subdural hematoma in the rat: effects of pretreatment with a glutamate antagonist1991 · 100 citations